| Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease J Quan, C Ma, R Panaccione, L Hracs, N Sharifi, M Herauf, A Makovinović, ... Gut 72 (4), 802-804, 2023 | 14 | 2023 |
| Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease J Quan, C Ma, R Panaccione, L Hracs, N Sharifi, M Herauf, ... The Lancet Gastroenterology & Hepatology 7 (12), 1077-1079, 2022 | 9 | 2022 |
| The 2023 impact of inflammatory bowel disease in Canada: Epidemiology of IBD S Coward, EI Benchimol, ME Kuenzig, JW Windsor, CN Bernstein, ... Journal of the Canadian Association of Gastroenterology 6 (Supplement_2), S9-S15, 2023 | 5 | 2023 |
| Serological responses to the first three doses of SARS-CoV-2 vaccination in inflammatory bowel disease: a prospective cohort study J Quan, C Ma, R Panaccione, L Hracs, N Sharifi, M Herauf, ... medRxiv, 2022.03. 16.22272440, 2022 | 3 | 2022 |
| S1004 Adverse Events and Serological Responses Following SARS-CoV-2 Vaccination in Individuals With Inflammatory Bowel Disease A Markovinovic, M Herauf, J Quan, L Hracs, J Windsor, N Sharifi, ... Official journal of the American College of Gastroenterology| ACG 117 (10S …, 2022 | 1 | 2022 |
| Adverse events and serological responses after SARS-coV-2 vaccination in individuals with inflammatory bowel disease A Markovinović, J Quan, M Herauf, L Hracs, JW Windsor, N Sharifi, ... Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022 | 1 | 2022 |
| MODELING THE TRANSITION TO THE FOURTH EPIDEMIOLOGIC STAGE OF INFLAMMATORY BOWEL DISEASE: PREVALENCE EQUILIBRIUM J Windsor, L Hracs, M Cummings, J Gorospe, M Buie, J Quan, ... Inflammatory Bowel Diseases 30 (Supplement_1), S33-S34, 2024 | | 2024 |
| TRENDS IN INFLAMMATORY BOWEL DISEASE INCIDENCE AND PREVALENCE ACROSS EPIDEMIOLOGIC STAGES: A GLOBAL SYSTEMATIC REVIEW WITH META-ANALYSIS J Gorospe, J Windsor, L Hracs, S Coward, M Buie, J Quan, L Caplan, ... Gastroenterology 166 (3), S56-S57, 2024 | | 2024 |
| MACHINE LEARNING CLASSIFICATION OF THE EPIDEMIOLOGIC STAGES OF INFLAMMATORY BOWEL DISEASE ACROSS GEOGRAPHY AND TIME L Hracs, J Windsor, J Gorospe, M Buie, J Quan, L Caplan, A Markovinovic, ... Inflammatory Bowel Diseases 30 (Supplement_1), S00-S00, 2024 | | 2024 |
| EXPLORING FACTORS ASSOCIATED WITH SEROLOGICAL RESPONSE TO SARS-COV-2 VACCINES IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE: INTERACTIVE VISUALIZATION METHODS FOR … L Hracs, J Quan, C Ma, R Panaccione, N Sharifi, M Herauf, ... Inflammatory Bowel Diseases 30 (Supplement_1), S31-S32, 2024 | | 2024 |
| The Global Evolution of Inflammatory Bowel Disease across Four Epidemiologic Stages G Kaplan, L Hracs, J Windsor, J Gorospe, M Cummings, S Coward, ... | | 2024 |
| Bivalent mRNA SARS-CoV-2 vaccination in patients with inflammatory bowel disease J Quan, A Markovinović, L Hracs, C Ma, R Panaccione, GG Kaplan, ... The Lancet Gastroenterology & Hepatology 8 (12), 1074-1075, 2023 | | 2023 |
| S1099 Comparison of Serological Responses to SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease Between Smokers and Non-Smokers K Ernest-Suarez, J Quan, F Yeaman, C Ma, R Panaccione, C Rowan, ... Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023 | | 2023 |
| S1100 Associations Between Body Mass Index and Serological Responses to SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease K Ernest-Suarez, F Yeaman, J Quan, C Rowan, C Ma, R Panaccione, ... Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023 | | 2023 |
| S1098 Serological Responses to SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease Are Impaired for Those on Anti-TNF and Immunomodulator Combination Therapy K Ernest-Suarez, C Rowan, J Quan, F Yeaman, C Ma, R Panaccione, ... Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023 | | 2023 |
| Blame attribution analysis of police motor vehicle collision reports involving child bicyclists L Caplan, B Lashewicz, TM Pitt, J Aucoin, L Fridman, T HubkaRao, I Pike, ... Injury prevention 29 (5), 407-411, 2023 | | 2023 |
| The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD GG Kaplan, ME Kuenzig, JW Windsor, CN Bernstein, A Bitton, S Coward, ... Journal of the Canadian Association of Gastroenterology 6 (Supplement_2 …, 2023 | | 2023 |
| Longitudinal Analysis of the Behavioral and Occupational Factors Present in Individuals Living with Inflammatory Bowel Disease during the COVID-19 Pandemic in Calgary, Alberta LN Caplan | | 2023 |
| Su1117 BIVALENT SARS-COV-2 VACCINATION YIELDS A STRONG SEROLOGICAL RESPONSE THAT IS COMPARABLE TO FOURTH DOSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE J Quan, A Markovinovice, C Ma, R Panaccione, L Hracs, N Sharifi, ... Gastroenterology 164 (6), S-532, 2023 | | 2023 |
| Sa1788 STABILITY OF SEROLOGICAL RESPONSES AFTER SECOND, THIRD AND FOURTH DOSE OF SARS-COV-2 VACCINATION IN INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY. N Sharifi, C Ma, CH Seow, J Quan, L Hracs, L Caplan, A Markovinovic, ... Gastroenterology 164 (6), S-431-S-432, 2023 | | 2023 |
